Machine learning-based radiomics models for the prediction of metachronous liver metastases in patients with colorectal cancer: A multimodal study

被引:0
作者
Wang, Jian-Ping [1 ]
Zhang, Ze-Ning [2 ]
Shu, Ding-Bo [1 ]
Huang, Ya-Nan [1 ]
Tang, Wei [1 ]
Zhao, Hong-Bo [1 ]
Zhao, Zhen-Hua [1 ,3 ]
Sun, Ji-Hong [2 ,4 ]
机构
[1] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Radiol, Shaoxing 312000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou 310016, Zhejiang, Peoples R China
[3] Zhejiang Univ, Shaoxing Peoples Hosp, Shaoxing Key Lab Funct Mol Imaging Tumor & Interve, Dept Radiotherapy,Shaoxing Hosp, Shaoxing 312000, Zhejiang, Peoples R China
[4] Zhejiang Univ, Canc Ctr, Hangzhou 310016, Zhejiang, Peoples R China
关键词
colorectal cancer; metachronous liver metastasis; radiomics; machine learning; multimodal;
D O I
10.3892/ol.2025.15140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate whether a multimodal radiomics model powered by machine learning could accurately predict the occurrence of metachronous liver metastasis (MLM) in patients with colorectal cancer (CRC). A total of 157 patients diagnosed with CRC between 2010 and 2020 were retrospectively included in the present study; of these patients, 67 patients developed liver metastases within 2 years of treatment, while the remaining patients (n=90) did not. Radiomics features were extracted from annotated MR images of the tumor and portal venous phase CT images of the liver in each patient. Subsequently, machine learning-based radiomics models were developed and integrated with the clinical features for MLM prediction, employing Least Absolute Shrinkage and Selection Operator and Random Forest algorithms. The performance of the models were evaluated using the receiver operating characteristic curve analysis, while the clinical utility was measured using the decision curve analysis. A total of 922 and 1,082 radiomics features were extracted from the MR and CT images of each patient, respectively, which quantified the intensity, shape, orientation and texture of the tumor and liver. The mean area under the curve (AUC) values for the prediction of MLM were 0.80, 0.68 and 0.82 for the CT, MRI and merged models, respectively. For the clinical and clinical-merged models, the AUC values were 0.62 and 0.75, respectively. There was no significant difference between the CT model and the merged model (P>0.05). In conclusion, the preliminary results of the present study demonstrated the utility of machine learning-based radiomics models in the prediction of MLM in patients with CRC. However, further research is warranted to explore the potential of multimodal fusion models, due to the minimal improvement observed in diagnostic performance.
引用
收藏
页数:11
相关论文
共 36 条
[1]   Predicting cancer outcomes with radiomics and artificial intelligence in radiology [J].
Bera, Kaustav ;
Braman, Nathaniel ;
Gupta, Amit ;
Velcheti, Vamsidhar ;
Madabhushi, Anant .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) :132-146
[2]   Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma [J].
Bo Z. ;
Song J. ;
He Q. ;
Chen B. ;
Chen Z. ;
Xie X. ;
Shu D. ;
Chen K. ;
Wang Y. ;
Chen G. .
Computers in Biology and Medicine, 2024, 173
[3]   Contemporary Surgical Management of Colorectal Liver Metastases [J].
Chandra, Pratik ;
Sacks, Greg D. .
CANCERS, 2024, 16 (05)
[4]   Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm [J].
Ciraci, Paolo ;
Studiale, Vittorio ;
Taravella, Ada ;
Antoniotti, Carlotta ;
Cremolini, Chiara .
NATURE REVIEWS CLINICAL ONCOLOGY, 2025, 22 (01) :28-45
[5]   Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer [J].
Creasy, John M. ;
Cunanan, Kristen M. ;
Chakraborty, Jayasree ;
McAuliffe, John C. ;
Chou, Joanne ;
Gonen, Mithat ;
Kingham, Victoria S. ;
Weiser, Martin R. ;
Balachandran, Vinod P. ;
Drebin, Jeffrey A. ;
Kingham, T. Peter ;
Jarnagin, William R. ;
D'Angelica, Michael I. ;
Do, Richard K. G. ;
Simpson, Amber L. .
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) :1982-1989
[6]   Assessment of tumor heterogeneity: An emerging imaging tool for clinical practice? [J].
Davnall F. ;
Yip C.S.P. ;
Ljungqvist G. ;
Selmi M. ;
Ng F. ;
Sanghera B. ;
Ganeshan B. ;
Miles K.A. ;
Cook G.J. ;
Goh V. .
Insights into Imaging, 2012, 3 (6) :573-589
[7]   Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Glynne-Jones, R. ;
Wyrwicz, L. ;
Tiret, E. ;
Brown, G. ;
Rodel, C. ;
Cervantes, A. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2017, 28 :22-40
[8]   Defining the biological basis of radiomic phenotypes in lung cancer [J].
Grossmann, Patrick ;
Stringfield, Olya ;
El-Hachem, Nehme ;
Bui, Marilyn M. ;
Velazquez, Emmanuel Rios ;
Parmar, Chintan ;
Leijenaar, Ralph T. H. ;
Haibe-Kains, Benjamin ;
Lambin, Philippe ;
Gilles, Robert J. ;
Aerts, Hugo J. W. L. .
ELIFE, 2017, 6
[9]   Cancer incidence and mortality in China, 2022 ☆ [J].
Han, Bingfeng ;
Zheng, Rongshou ;
Zeng, Hongmei ;
Wang, Shaoming ;
Sun, Kexin ;
Chen, Ru ;
Li, Li ;
Wei, Wenqiang ;
He, Jie .
JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (01) :47-53
[10]   Which patients are prone to suffer liver metastasis? A review of risk factors of metachronous liver metastasis of colorectal cancer [J].
Hao, Mengdi ;
Wang, Kun ;
Ding, Yuhan ;
Li, Huimin ;
Liu, Yin ;
Ding, Lei .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)